AllPaisa
← All instruments

Tyche Industries Ltd.

StockBSE: 532384· Healthcare· Pharmaceuticals· Face value ₹10

₹124.10

1.51%

Delayed · as of 07 Aug 2026

Dividend per share by financial year

Dividend per share by financial year
Financial yearTotal dividend
FY02₹0.50
FY08₹1.50
FY09₹0.50
FY10₹0.50
FY11₹0.50
FY12₹0.50
FY13₹0.50
FY14₹0.50
FY15₹0.50
FY16₹0.50
FY17₹0.50
FY18₹0.50
FY19₹0.50
FY20₹0.50
FY21₹1.00
FY22₹1.00
FY23₹1.50
FY24₹2.00
FY25₹2.50
FY26₹3.00
Dividend per share. Latest year on record: FY26.

Recent payouts

20 on record since FY02
TypeAmountEx-date
FINAL₹3.0019 Sep 2025
FINAL₹2.5020 Sep 2024
FINAL₹2.0022 Aug 2023
FINAL₹1.5022 Sep 2022
FINAL₹1.0022 Sep 2021
Against the marketIndex yields as of 07 Aug 2026+ Show
This dividend yield
2.42%
Nifty 50
1.27%
1.9× the index
Nifty Dividend Opportunities 50
2.26%
1.1× the index

Index dividend yields are published by NSE alongside the closing levels. The dividend index is the fairer comparison: measured against the broad market almost every instrument here looks generous. A higher yield is not automatically better — it can mean a falling price as easily as a rising payout, which is what the chart above separates.

Yield through time

246 sessions · 07 Aug 202507 Aug 2026

Trailing twelve-month payout divided by that session’s closing price, so a move here is either the payout changing or the price changing — the two readings a single current yield cannot tell apart. Ranged 1.74% to 3.84% over this window, ending at 2.42%. Closes and payouts are both split-adjusted, so a split does not appear as a change in yield. Tap or drag the chart to read a single session.

Others in Pharmaceuticals6 instruments+ Show

Similar current yields

Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.

This site uses Google Analytics to see which pages people find useful. Google receives page views, IP-derived approximate location, device and browser type, and the referring site. Privacy details.